Literature DB >> 28205008

Laparoscopic Conversion of Omega Loop Gastric Bypass into Roux-en-Y Gastric Bypass.

Radwan Kassir1,2, Talal Alamri3, Patrice Lointier4.   

Abstract

ᅟ.

Keywords:  Bariatric surgery; Gasterojejunal anastomosis; Omega loop gastric bypass; Roux-en-Y gastric bypass

Mesh：

Year:  2017        PMID： 28205008     DOI： 10.1007/s11695-017-2591-z

Source DB:  PubMed          Journal:  Obes Surg        ISSN： 0960-8923            Impact factor:   4.129


× No keyword cloud information.
  10 in total

1.  Baseline data from American Society for Metabolic and Bariatric Surgery-designated Bariatric Surgery Centers of Excellence using the Bariatric Outcomes Longitudinal Database.

Authors:  Eric J DeMaria; Virginia Pate; Michael Warthen; Deborah A Winegar
Journal:  Surg Obes Relat Dis       Date:  2010-01-04       Impact factor: 4.734

2.  Laparoscopic Roux-en-Y versus mini-gastric bypass for the treatment of morbid obesity: a prospective randomized controlled clinical trial.

Authors:  Wei-Jei Lee; Po-Jui Yu; Weu Wang; Tai-Chi Chen; Po-Li Wei; Ming-Te Huang
Journal:  Ann Surg       Date:  2005-07       Impact factor: 12.969

3.  The mini-gastric bypass: experience with the first 1,274 cases.

Authors:  R Rutledge
Journal:  Obes Surg       Date:  2001-06       Impact factor: 4.129

Review 4.  Efficacy and safety of laparoscopic mini gastric bypass. A systematic review.

Authors:  Despoina Georgiadou; Theodoros N Sergentanis; Alexander Nixon; Theodoros Diamantis; Christos Tsigris; Theodora Psaltopoulou
Journal:  Surg Obes Relat Dis       Date:  2014-02-15       Impact factor: 4.734

5.  Continued excellent results with the mini-gastric bypass: six-year study in 2,410 patients.

Authors:  Robert Rutledge; Thomas R Walsh
Journal:  Obes Surg       Date:  2005-10       Impact factor: 4.129

6.  Greater weight loss with the omega loop bypass compared to the Roux-en-Y gastric bypass: a comparative study.

Authors:  E Disse; A Pasquer; P Espalieu; G Poncet; C Gouillat; M Robert
Journal:  Obes Surg       Date:  2014-06       Impact factor: 4.129

7.  Laparoscopic Roux-en-Y vs. mini-gastric bypass for the treatment of morbid obesity: a 10-year experience.

Authors:  Wei-Jei Lee; Kong-Han Ser; Yi-Chih Lee; Jun-Juin Tsou; Shu-Chun Chen; Jung-Chien Chen
Journal:  Obes Surg       Date:  2012-12       Impact factor: 4.129

8.  One thousand consecutive mini-gastric bypass: short- and long-term outcome.

Authors:  Roger Noun; Judith Skaff; Edward Riachi; Ronald Daher; Nayla Abi Antoun; Marwan Nasr
Journal:  Obes Surg       Date:  2012-05       Impact factor: 4.129

9.  Five-year outcomes of laparoscopic adjustable gastric banding and laparoscopic Roux-en-Y gastric bypass in a comprehensive bariatric surgery program in Canada.

Authors:  Nicolas Christou; Evangelos Efthimiou
Journal:  Can J Surg       Date:  2009-12       Impact factor: 2.089

10.  Laparoscopic mini-gastric bypass (LMGB) in the super-super obese: outcomes in 16 patients.

Authors:  Cesare Peraglie
Journal:  Obes Surg       Date:  2008-06-25       Impact factor: 4.129
  10 in total
  3 in total

1.  Barrett's Oesophagus and Oesophageal Carcinogenesis Following Obesity Surgery: Helicobacter Pylori Must Be Eradicated?

Authors:  Radwan Kassir; Patrice Lointier; Jean-Marc Phelip; Axel Denneval; Nicolas Williet; Olivier Tiffet
Journal:  Obes Surg       Date:  2017-09       Impact factor: 4.129

2.  Comparison of the Bile Reflux Frequency in One Anastomosis Gastric Bypass and Roux-en-Y Gastric Bypass: a Cohort Study.

Authors:  Behrouz Keleidari; Mohsen Mahmoudieh; Amir Hosein Davarpanah Jazi; Hamid Melali; Farid Nasr Esfahani; Mohammad Minakari; Mojgan Mokhtari
Journal:  Obes Surg       Date:  2019-06       Impact factor: 4.129

3.  Applying an Anti-reflux Suture in the One Anastomosis Gastric Bypass to Prevent Biliary Reflux: a Long-Term Observational Study.

Authors:  Nienke Slagter; Jonne Hopman; Anna G Altenburg; Loek J M de Heide; Ewoud H Jutte; Mirjam A Kaijser; Stefan L Damen; André P van Beek; Marloes Emous
Journal:  Obes Surg       Date:  2021-01-26       Impact factor: 4.129
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.